American Oncology Network (AONC): Prakiraan wutah bathi kanggo taun ngarep

Logo korporat perusahaan American Oncology Network Inc (AONC)

American Oncology Network (AONC) relies on the defensive nature of healthcare, where demand for cancer therapy remains independent of GDP. The company's growth is based on the consolidation of private practices and the implementation of new technologies. However, debt load and insurance tariffs create certain risks. Net income per share expectations in the GURU.Markets chart timeline show a trend where the 0.00 mark serves as a key metric.

American Oncology Network Inc (AONC): Prakiraan wutah bathi saben saham kanggo taun ngarep saka 21.02.2024 nganti 04.08.2024

American Oncology Network Inc - rincian analitis lan metrik utama (AONC)

Analisis wiwitan perusahaan:American Oncology Network Inc, AONC
Barang utama American Oncology Network, Inc.

The earnings growth forecast for the coming year determines the expected EPS trajectory, reflecting the level of fundamental market confidence in the business's future profitability. By analyzing the earnings per share growth model for next year, an investor assesses the gap between the current price and analysts' consensus forecasts. For American Oncology Network (AONC), this indicator measures the scaling efficiency of the oncology center management platform and the monetization rates of administrative support for regional clinics.

Analisis perusahaan pesaing

ONC (BeiGene Ltd) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Halozyme Therapeutics HALO|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Revolution Medicines, Inc. (RVMD)|Prakiraan wutah bathi kanggo taun ngarep Ascentage Pharma Group International (AAPG)|Prakiraan wutah bathi kanggo taun ngarep CGON (CG Oncology Inc)|Dinamika bathi saben saham sing diarepake ing taun ngarep URGN|bicara.com - Prakiraan wutah bathi kanggo taun ngarep|Dinamika bathi saben saham sing diarepake ing taun ngarep PSNL (personalis.com)|Erasca Inc (ERAS) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan wutah bathi saben saham kanggo taun ngarep Delcath Systems|YMAB (YmAbs) - Prakiraan wutah bathi kanggo taun ngarep|AURA: Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Candel Therapeutics, Inc. (CADL)|Prakiraan wutah bathi kanggo taun ngarep Accuray (ARAY)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep SELLAS Life Sciences Group Inc. SLS|Actuate Therapeutics, Inc (ACTU) - Prakiraan wutah bathi resik saben saham ing taun ngarep|CTOR - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|HURA: Prakiraan wutah bathi resik saben saham kanggo taun ngarep|TARA (Protara) - Prakiraan wutah bathi saben saham kanggo taun ngarep|Fate Therapeutics, Inc. - Dinamika bathi saben saham sing diarepake ing taun ngarep|WHWK (aadibio.com) - Prakiraan wutah bathi kanggo taun ngarep|TCRX: Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Champions Oncology (CSBR)|XBiotech - Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep CEL-SCI CVM|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep OS Therapies (OSTX)|Radiopharm Theranostics Limited - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Artiva Biotherapeutics|ANL (adlainortye.com) - Prakiraan wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi saben saham kanggo taun ngarep Veru Pharma|TPST (Tempest Therapeutics Inc) - Prakiraan wutah bathi kanggo taun ngarep|Xilio Therapeutics, Inc. (XLO) - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Enochian BioSciences (RENB)|MURA: Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep KAPA (kairospharma.com)|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep OnKure (OKUR)|CytoMed Therapeutics Ltd - Prakiraan wutah bathi kanggo taun ngarep|curis.com (CRIS) - Prakiraan wutah bathi saben saham kanggo taun ngarep|Apollomics Corp (APLM) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Tharimmune - Dinamika bathi saben saham sing diarepake ing taun ngarep|ADVB (Advanced Biomed Corp) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi saben saham kanggo taun ngarep Genprex, Inc (GNPX)|Prakiraan wutah bathi kanggo taun ngarep CLDI|SBFM: Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep XBIO (xeneticbio.com)|Prakiraan wutah bathi kanggo taun ngarep Salarius Pharmaceuticals Inc SLRX|purple-biotech.com - Prakiraan wutah bathi kanggo taun ngarep|Dinamika bathi saben saham sing diarepake ing taun ngarep BGNE (BeOne Medicines)|CKPT: Prakiraan wutah bathi kanggo taun ngarep|Elevation Oncology Inc. (ELEV) - Prakiraan wutah bathi kanggo taun ngarep|ICAD (iCAD) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep ikenaoncology.com|Prakiraan wutah bathi kanggo taun ngarep NTBL|Prakiraan wutah bathi kanggo taun ngarep Viracta Therapeutics Inc. (VIRX)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep MorphoSys Inc MOR|Dinamika bathi saben saham sing diarepake ing taun ngarep NAYA|AAPGV: Prakiraan wutah bathi saben saham kanggo taun ngarep